FDA Reopens Debate on Over-the-Counter “Morning After Pill”
By Peter J. Smith WASHINGTON, D.C., July 31, 2006 (LifeSiteNews.com) – The United States’ Food and Drug Administration (FDA) is considering once again to allow over-the-counter sales of the abortifacient morning-after pill, “Plan B”, just a day before the Senate begins confirmation hearings over Dr. Andrew von Eschenbach, President Bush’s nominee to head the FDA. Early Monday, the FDA contacted Barr Laboratories Inc., the manufacturer of the “emergency contraceptive” Plan B, indicating that it wanted to meet within seven days to discuss new steps the company must take in order to sell the abortifacient without a prescription. Last August, the […]
•